Search - tctmd.com

Displaying 161 - 180 of 460

Sort: Relevancy | Date

News Daily News

As TAVR Evolves, Local Anesthesia Could Be an Option for Lower-Risk Patients

Yael L. Maxwell

April 03, 2015

News Industry News

Medtronic CoreValve® System Receives FDA Approval for Transcatheter Valve-In-Valve Procedures

March 31, 2015

News Industry News

Medtronic Announces Japanese Regulatory Approval of CoreValve® System

March 30, 2015

News Daily News

PARTNER at 5 Years: TAVR Shows Durable Benefit in Inoperable Patients

March 25, 2015

News Conference News ACC 2015

ACC-i2 2015: Strategies to Enhance PCI Results, TAVR Highlighted

Todd Neale

March 20, 2015

News Conference News ACC 2015

Thirty-day Outcomes with Sapien 3 Lowest Seen with Balloon-Expandable TAVR

Yael L. Maxwell

March 15, 2015

News Industry News

Medtronic CoreValve® System Sustains Superior Survival Benefit Over Open Heart Surgery at Two Years

March 15, 2015

News Conference News ACC 2015

Follow-up TAVR Studies Reassure About Valve Durability, Outcomes

Todd Neale

March 15, 2015

News Industry News

Five-Year Outcomes For High-Risk Sapien Patients Demonstrate Equivalence To Surgery, Durable Valve Performance

March 15, 2015

Presentation ACC 2015

Five-Year Outcomes after Randomization to Transcatheter or Surgical Aortic Valve Replacement: Final Results of The PARTNER 1 Trial

Presenter: Michael J. Mack

March 15, 2015

Presentation ACC 2015

A Randomized Comparison of Self-expanding Transcatheter and Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis Deemed at Increased Risk for Surgery 2-Year Outcomes

Presenter: Michael J. Reardon

March 15, 2015

News Daily News

TVT Registry Provides Picture of TAVR Risk Factors, 1-Year Outcomes

L.A. McKeown

March 10, 2015

News Daily News

Valvuloplasty Improves Short-term Outlook for Patients With Medically Managed Aortic Stenosis

February 19, 2015

News Daily News

TAVR可改善大多数高危患者的健康相关生活质量

L.A. McKeown

February 19, 2015

News Daily News

TAVR Mejora la Calidad de Vida asociada a la Salud en la Mayoría de Pacientes de Riesgo Extremo

L.A. McKeown

February 19, 2015

News Daily News

TAVR Improves Health-Related QoL in Majority of Extreme-Risk Patients

L.A. McKeown

February 19, 2015

News Daily News

Most Late Cardiac Mortality After TAVR Due to Heart Failure, Sudden Cardiac Death

Yael L. Maxwell

February 02, 2015

News Daily News

PARTNER Registry Documents Strides Made in Transfemoral TAVR

L.A. McKeown

December 04, 2014

News Daily News

Transfusions Linked to Increased Mortality in Anemic TAVR Patients

L.A. McKeown

November 02, 2014

News Features TCT 2014

Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease

Todd Neale

October 24, 2014

Advertisement

As TAVR Evolves, Local Anesthesia Could Be an Option for Lower-Risk Patients

Medtronic CoreValve® System Receives FDA Approval for Transcatheter Valve-In-Valve Procedures

Medtronic Announces Japanese Regulatory Approval of CoreValve® System

PARTNER at 5 Years: TAVR Shows Durable Benefit in Inoperable Patients

ACC-i2 2015: Strategies to Enhance PCI Results, TAVR Highlighted

Thirty-day Outcomes with Sapien 3 Lowest Seen with Balloon-Expandable TAVR

Medtronic CoreValve® System Sustains Superior Survival Benefit Over Open Heart Surgery at Two Years

Follow-up TAVR Studies Reassure About Valve Durability, Outcomes

Five-Year Outcomes For High-Risk Sapien Patients Demonstrate Equivalence To Surgery, Durable Valve Performance

Five-Year Outcomes after Randomization to Transcatheter or Surgical Aortic Valve Replacement: Final Results of The PARTNER 1 Trial

A Randomized Comparison of Self-expanding Transcatheter and Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis Deemed at Increased Risk for Surgery 2-Year Outcomes

TVT Registry Provides Picture of TAVR Risk Factors, 1-Year Outcomes

Valvuloplasty Improves Short-term Outlook for Patients With Medically Managed Aortic Stenosis

TAVR可改善大多数高危患者的健康相关生活质量

TAVR Mejora la Calidad de Vida asociada a la Salud en la Mayoría de Pacientes de Riesgo Extremo

TAVR Improves Health-Related QoL in Majority of Extreme-Risk Patients

Most Late Cardiac Mortality After TAVR Due to Heart Failure, Sudden Cardiac Death

PARTNER Registry Documents Strides Made in Transfemoral TAVR

Transfusions Linked to Increased Mortality in Anemic TAVR Patients

Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content